Matthew Hewitt, PhD, currently serves as the Executive Director, Scientific Services, Cell & Gene Therapy (CGT) at Charles River Laboratories (CRL). In this role, Matt leads one of Charles River’s CGT CDMO sites in helping partners move assets to clinic and commercial. Matt is also responsible for leading conversations on CRL’s cell and gene therapy strategic approach